Equities

Kohjin Bio Co Ltd

177A:TYO

Kohjin Bio Co Ltd

Actions
  • Price (JPY)1,909.00
  • Today's Change61.00 / 3.30%
  • Shares traded15.40k
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments1,7271,4631,734
Total Receivables, Net9278471,151
Total Inventory6831,103521
Prepaid expenses------
Other current assets, total736727
Total current assets3,4103,4793,434
Property, plant & equipment, net2,5872,1721,709
Goodwill, net------
Intangibles, net2.994.375.97
Long term investments482410390
Note receivable - long term------
Other long term assets715954
Total assets6,5896,1355,595
LIABILITIES
Accounts payable247236396
Accrued expenses647660
Notes payable/short-term debt1,5001,200900
Current portion long-term debt/capital leases203885230
Other current liabilities, total385624612
Total current liabilities2,3983,0222,198
Total long term debt767151,099
Total debt2,4702,1002,229
Deferred income tax----9.23
Minority interest------
Other liabilities, total828072
Total liabilities3,2473,1173,378
SHAREHOLDERS EQUITY
Common stock427427427
Additional paid-in capital326326326
Retained earnings (accumulated deficit)2,5292,2231,435
Treasury stock - common------
Unrealized gain (loss)2.952.672.87
Other equity, total584027
Total equity3,3423,0182,217
Total liabilities & shareholders' equity6,5896,1355,595
Total common shares outstanding5.025.025.02
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.